|
Androgen Receptor Pathway Inhibitor Clinical Trials
1 actively recruiting trial across 1 location
Also known as: AR Pathway Inhibitor, AR Signaling Inhibitor, AR Signaling Pathway Inhibitor, ARPI, ARSI +1 more
Pipeline
Phase 2: 1
Top Sponsors
- Fred Hutchinson Cancer Center1
Indications
- Metastatic Castration-Sensitive Prostate Adenocarcinoma1
- Castration-Sensitive Prostate Adenocarcinoma1
- Stage IVB Prostate Cancer AJCC v81
- Cancer1
Seattle, Washington1 trial
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
Fred Hutch/University of Washington Cancer Consortium
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.